Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ZyVersa Therapeutics Inc.

    NASDAQ: ZVSA · Real-Time Price · USD
    0.67
    0.04 (6.01%)
    At close: Jun 17, 2025, 10:15 AM

    ZyVersa Therapeutics Statistics

    Share Statistics

    ZyVersa Therapeutics has 4.77M shares outstanding. The number of shares has increased by 200.42% in one year.

    Shares Outstanding

    n/a
    		 4.77M

    Shares Change (YoY)

    n/a
    		 200.42%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 4.76M

    Failed to Deliver (FTD) Shares

    n/a
    		 89,325

    FTD / Avg. Volume

    n/a
    		 2.43%

    Short Selling Information

    The latest short interest is 300.95K, so 6.3% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 300.95K

    Short % of Shares Out

    n/a
    		 6.3%

    Short % of Float

    n/a
    		 6.31%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 -0.01

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -1.56

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ZyVersa Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.15, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 0.15

    Quick Ratio

    n/a
    		 0.15

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -33858.18

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,344,776,428.57

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -6.75M

    Effective Tax Rate

    n/a
    		 0.07%

    Stock Price Statistics

    The stock price has increased by -87.81% in the last 52 weeks. The beta is 0.74, so ZyVersa Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.74

    52-Week Price Change

    n/a
    		 -87.81%

    50-Day Moving Average

    n/a
    		 0.65

    200-Day Moving Average

    n/a
    		 1.3

    Relative Strength Index (RSI)

    n/a
    		 49.19

    Average Volume (20 Days)

    n/a
    		 3,682,514

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -9.14B

    Net Income

    n/a
    		 -9.41B

    EBITDA

    n/a
    		 -9.14B

    EBIT

    n/a
    		 -9.15B

    Earnings Per Share (EPS)

    n/a
    		 -848.03
    Full Income Statement

    Balance Sheet

    The company has 1.53M in cash and 0 in debt, giving a net cash position of 1.53M.

    Cash & Cash Equivalents

    n/a
    		 1.53M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -112.63B

    Total Assets

    n/a
    		 20.99B

    Working Capital

    n/a
    		 -9.89B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -7.56M and capital expenditures 0, giving a free cash flow of -7.56M.

    Operating Cash Flow

    n/a
    		 -7.56M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -7.56M

    FCF Per Share

    n/a
    		 -0.68
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ZVSA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ZVSA is $240, which is 37400% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $240

    Price Target Difference

    n/a
    		 37400%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 26, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Apr 26, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -8.57

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist